Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.